"Nothing better than your own from birth" ? That is not what the company has been saying. The company puts a value on cells for use in other people with very little for autologous use. That is one of the big problems I have with what the company is worth.
Paul, what will CBAI do when physicians are able to harvest stem cells straight from a sick person and use those cells to cure them of their illness? We both know there are many companies working on just that.
News 
Market Data 
Discover 
